DEAR DR. FOX: I visited your website in my search to make sense out of vaccination recommendations, both for animals and people. There is so much misinformation and so many conspiracy theories out there.
Robert F. Kennedy Jr., an anti-vaxxer, has replaced the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices with his own cadre of people. What’s going on, and where do we go from here? -- I.P., West Palm Beach, Florida
DEAR I.P.: You know from my previous posts on vaccinations (see drfoxonehealth.com/post/animal-vaccination-concerns-vaccine-associated-autoimmune-and-other-diseases) that I am not opposed to the judicious use of vaccines, for humans and for companion animals, as long as caution is applied. However, I am concerned about the new generation of mRNA vaccines that the CDC approved for human use at the onset of the COVID-19 pandemic.
The COVID-19 mRNA vaccines were brought to market as quickly as possible, given the severity of the pandemic. Now, governmental health agencies are assessing the costs, consequences, risks and benefits of that haste. From the data that I have seen on adverse reactions, hearings are called for.
In my opinion, the risks of mRNA vaccines -- products of genetic engineering and biotechnology -- have never been fully addressed or exposed by the manufacturers, nor by the governmental health regulatory agencies promoting their use. The precautionary principle needs to be more rigorously adopted. RFK Jr.’s new CDC vaccine panel will, hopefully, rise to the challenge, applying sound science to their decision-making.
Below are some studies, articles and other links of interest on the subject.
-- Some adverse effects were documented by Joseph Fraiman et al. in the study "Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults," published in Vaccine in 2022. The authors state: “The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes.”
-- Yale News (news.yale.edu) ran an article in February entitled "Immune markers of post-vaccination syndrome indicate future research directions." It states that “some individuals have reported chronic symptoms that developed soon after receiving a COVID-19 vaccine. This little-understood, persistent condition, referred to as post-vaccination syndrome (PVS), remains unrecognized by medical authorities, and little is known about its biological underpinnings. ... Some of the most common chronic symptoms of PVS include exercise intolerance, excessive fatigue, brain fog, insomnia and dizziness. They develop shortly after vaccination, within a day or two, can become more severe in the days that follow, and persist over time. More studies are needed to understand the prevalence of PVS.”
-- Per Reuters, on Dec. 6, U.S. District Judge Mark T. Pittman ordered the U.S. Food and Drug Administration to publicly release all data and information submitted to the FDA underpinning the agency’s first-ever Emergency Use Authorization, granted for the Pfizer-BioNTech COVID-19 vaccine in 2020.
-- The U.S. government’s National Vaccine Injury Compensation Program provides liability protections to vaccine manufacturers and vaccine administrators who administer covered vaccines in many circumstances; however, these protections are not absolute. For details, see hrsa.gov/vaccine-compensation/faq.
-- The use of mRNA vaccines in livestock is opposed by the U.S. Cattlemen’s Association, at least “until scientifically sound raw data is available for open review by researchers with no conflicts of interest, and publicly available research studies are published and peer-reviewed on the short- and long-term health, safety and fertility effects" of such products on the inoculated animals, as well as on the humans who consume their meat or milk. (Full statement: uscattlemen.org/usca-establishes-policy-regarding-mrna-technologies.)
-- An mRNA vaccine is being developed to prevent feline infectious peritonitis in cats. See the study "Feline Infectious Peritonitis mRNA Vaccine Elicits Both Humoral and Cellular Immune Responses in Mice" by Terza Brostoff et al., published in Vaccines in 2024.
(Send all mail to animaldocfox@gmail.com or to Dr. Michael Fox in care of Andrews McMeel Syndication, 1130 Walnut St., Kansas City, MO 64106. The volume of mail received prohibits personal replies, but questions and comments of general interest will be discussed in future columns.
Visit Dr. Fox’s website at DrFoxOneHealth.com.)